Oncotarget

Corrections:

Correction: Tumor-associated macrophages promote tumor metastasis via the TGF-β/SOX9 axis in non-small cell lung cancer

PDF  |  How to cite

Oncotarget. 2020; 11:4845-4846. https://doi.org/10.18632/oncotarget.27740

Metrics: PDF 211 views  |   ?  

Shuai Zhang1, Dehai Che1, Fang Yang1, Chunling Chi2, Hongxue Meng3, Jing Shen1, Li Qi4, Fang Liu1, Liyan Lv5, Yue Li1, Qingwei Meng1, Junning Liu6, Lihua Shang1 and Yan Yu1

1 The Sixth Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China
2 Department of Neurology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China
3 Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, China
4 Department of Oncology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
5 Department of Oncology, The First Affiliated Hospital of Harbin Medical University, Harbin, China
6 Department of Oncology, The First Affiliated Hospital of Qiqihar Medical College, Qiqihar, China

Published: December 29, 2020

Copyright: © 2020 Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been corrected: Due to errors in image selection, the pictures of H1299 cell morphology treated with recombinant TGF-β and TGF-β receptor inhibitor in Figure 5A are incorrect. When preparing the results, the control group data was mistakenly copied and presented as the treatment group. The corrected Figure 5 is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original article: Oncotarget. 2017; 8:99801–99815. DOI: https://doi.org/10.18632/oncotarget.21068.

Figure 5: TGF-β increased SOX9 expression and induced transformation into an EMT-like phenotype in lung cancer cells. (A) Changes in lung cancer cell morphology after recombinant TGF-β (10ng/ml) or TGF-β receptor inhibitor (TGFR I, SD208, 1μM) was added to A549 and H1299 cell culture systems for 24 or 48 h. (B–C) Changes in SOX9, E-cadherin, and vimentin protein (B) and mRNA (C) levels in lung cancer cells after recombinant TGF-β or TGFR I was added to A549 and H1299 cell culture systems for 48 h. ***p < 0.01, mean ± SEM.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 27740